{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:08:24Z","timestamp":1791198504975,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.exer.2007.03.003","type":"journal-article","created":{"date-parts":[[2007,3,20]],"date-time":"2007-03-20T06:51:22Z","timestamp":1174373482000},"page":"44-53","source":"Crossref","is-referenced-by-count":23,"title":["Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo"],"prefix":"10.1016","volume":"85","author":[{"given":"Peter","family":"Szurman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslaw","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine B.","family":"Jaissle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wallenfels-Thilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"L\u00fcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl U.","family":"Bartz-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2007.03.003_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jps.2600650329","article-title":"Aqueous solubility of 14C-triamcinolone acetonide","volume":"65","author":"Behl","year":"1976","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.exer.2007.03.003_bib2","first-page":"1001.e1","article-title":"Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials","volume":"113","author":"D'Amico","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2007.03.003_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00006982-200003000-00004","article-title":"Intravitreal triamcinolone acetonide in exudative age-related macular degeneration","volume":"20","author":"Danis","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.exer.2007.03.003_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","article-title":"ARPE-19, a human retinal pigment epithelial cell line with differentiated properties","volume":"62","author":"Dunn","year":"1996","journal-title":"Exp. Eye. Res."},{"key":"10.1016\/j.exer.2007.03.003_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00006982-200312000-00029","article-title":"Triamcinolone acetonide-assisted\u00a0peeling of retinal internal limiting membrane for macular surgery","volume":"23","author":"Fraser","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.exer.2007.03.003_bib6","series-title":"Diffusion Phenomena in Thin Films and Microelectronic Materials","article-title":"Some formal aspects of diffusion","author":"Gupta","year":"1988"},{"key":"10.1016\/j.exer.2007.03.003_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/jps.2600721221","article-title":"Stability of triamcinolone acetonide solutions as determined by high-performance liquid chromatography","volume":"72","author":"Gupta","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.exer.2007.03.003_bib8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3928\/1542-8877-20040701-18","article-title":"A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection","volume":"35","author":"Hernaez-Ortega","year":"2004","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"10.1016\/j.exer.2007.03.003_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0002-9394(86)90593-3","article-title":"Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations","volume":"101","author":"Hida","year":"1986","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2007.03.003_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00347-003-0975-z","article-title":"Ocular side effects and complications of intravitreal triamcinolone acetonide injection","volume":"101","author":"Jaissle","year":"2004","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.exer.2007.03.003_bib11","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bjo.84.9.1064","article-title":"Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy","volume":"84","author":"Jonas","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2007.03.003_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for diffuse diabetic macular edema","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2007.03.003_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.eye.6701438","article-title":"Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study","volume":"19","author":"Jonas","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.exer.2007.03.003_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000093796","article-title":"Intravitreal triamcinolone acetonide: a change in a paradigm","volume":"38","author":"Jonas","year":"2006","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2007.03.003_bib15","first-page":"63","volume":"12","author":"Kong","year":"1998","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.exer.2007.03.003_bib16","first-page":"171","article-title":"Treatment of intraocular proliferations with intravitreal steroids","volume":"77","author":"Machemer","year":"1979","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.exer.2007.03.003_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1076\/ceyr.27.6.395.18189","article-title":"Ultrastructure of the vitreoretinal interface following the removal of the internal limiting membrane using indocyanine green","volume":"27","author":"Nakamura","year":"2003","journal-title":"Curr. Eye. Res."},{"key":"10.1016\/j.exer.2007.03.003_bib18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1167\/iovs.05-0772","article-title":"Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells","volume":"47","author":"Narayanan","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2007.03.003_bib19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00006982-200312000-00005","article-title":"Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter","volume":"23","author":"Nishimura","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.exer.2007.03.003_bib20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006982-200005000-00024","article-title":"Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloids during pars plana vitrectomy","volume":"20","author":"Peyman","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.exer.2007.03.003_bib21","doi-asserted-by":"crossref","first-page":"632.e1","DOI":"10.1016\/j.ophtha.2006.01.027","article-title":"Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration","volume":"113","author":"Rosenfeld","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2007.03.003_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/00006982-200507000-00024","article-title":"Adherence of intravitreally injected triamcinolone acetonide to the denuded retinal surface after internal limiting membrane peeling","volume":"25","author":"Satofuka","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.exer.2007.03.003_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(82)90130-1","article-title":"The clearance of intravitreal triamcinolone acetonide","volume":"93","author":"Schindler","year":"1982","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2007.03.003_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/bjo.2005.076190","article-title":"Cell viability effects of triamcinolone acetonide and preservative vehicle formulations","volume":"90","author":"Shaikh","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2007.03.003_bib25","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bjo.2004.062596","article-title":"Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema","volume":"89","author":"Spandau","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2007.03.003_bib26","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/bjo.2006.095190","article-title":"Antiproliferative and cytotoxic properties of bevacizumab (Avastin) on different ocular cells","volume":"90","author":"Spitzer","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2007.03.003_bib27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.exer.2006.02.012","article-title":"Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells","volume":"83","author":"Szurman","year":"2006","journal-title":"Exp. Eye. Res."},{"key":"10.1016\/j.exer.2007.03.003_bib28","unstructured":"Szurman, P., Kaczmarek, R., Jaissle, G.B., Grisanti, S., L\u00fcke, M., Spitzer, M.S., Heide, P.E., Bartz-Schmidt, K.U. Influence of different purification techniques on triamcinolone yield and particle size spectrum. Graefes Arch. Clin. Exp. Ophthalmol., in press (Epub Sep 28)."},{"key":"10.1016\/j.exer.2007.03.003_bib29","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1167\/iovs.03-0490","article-title":"The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone","volume":"44","author":"Yeung","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483507000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483507000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T09:53:24Z","timestamp":1556272404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483507000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0014483507000814"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2007.03.003","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}